NCT07028268 - A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2027

Conditions

For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors

Interventions

DRUG

SHR-2017、Denosumab placebo

SHR-2017; high dose ；Denosumab placebo

DRUG

SHR-2017、Denosumab placebo

SHR-2017; low dose ；Denosumab placebo

DRUG

Denosumab；SHR-2017 placebo

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY